Oxytocin Receptors in the Developing Human Penis

The oxytocin receptor (OXTR) is widely recognised for its roles in parturition, lactation, and social bonding. Less well known is the accumulating evidence that OXTR is expressed in the male reproductive tract – including the human penis – during critical windows of prenatal and postnatal development. Pioneering work by Almut Einspanier, Richard Ivell, and colleagues first demonstrated OXTR expression in human penile tissue, raising fundamental questions about the role of oxytocin receptor signalling in penile morphogenesis, smooth muscle differentiation, and the ontogeny of erectile function. This article reviews the evidence for oxytocin receptor expression during penile development, the developmental biology context, and the potential implications for reproductive physiology and clinical medicine.

The Oxytocin Receptor: Molecular and Structural Overview

The oxytocin receptor is a 389-amino acid transmembrane protein belonging to the class A (rhodopsin-like) family of G-protein coupled receptors. It is encoded by the OXTR gene on human chromosome 3p25.3. Upon binding its ligand – the nine-amino acid cyclic peptide oxytocin – the receptor activates the Gq/11 signalling cascade, leading to phospholipase C-β activation, inositol-1,4,5-trisphosphate (IP3) production, and intracellular calcium mobilisation (Gimpl & Fahrenholz, 2001).

While OXTR expression has been extensively characterised in the myometrium, mammary gland, and brain, its presence in the male reproductive system received relatively little attention until the mid-1990s. The recognition that oxytocin functions as more than a “cuddle hormone” – acting as a local paracrine and autocrine signalling molecule in diverse tissues – prompted systematic surveys of OXTR expression across organ systems, including male reproductive structures.

Discovery of OXTR in Human Penile Tissue

Einspanier & Ivell (1997) published the first comprehensive analysis of oxytocin receptor expression in the human male reproductive tract. Using RT-PCR with primers specific to the OXTR coding sequence, they detected OXTR mRNA in testicular tissue, epididymis, prostate, and – notably – the penis. In situ hybridisation on tissue sections localised OXTR transcripts to specific cell populations within penile tissue, including smooth muscle cells of the corpus cavernosum and vascular wall cells of the deep penile arteries.

This study was groundbreaking because it demonstrated that the human penis possesses the molecular machinery for direct oxytocin responsiveness, establishing a biological substrate for peripheral oxytocin effects on erectile function that had been hypothesised but not previously demonstrated in human tissue. The findings complemented concurrent work in the rat model by the Argiolas laboratory showing functional OXTR-mediated smooth muscle contraction in rat penile tissue.

Methodological Considerations

The Einspanier and Ivell studies employed several complementary techniques to confirm OXTR expression. RT-PCR provided evidence of mRNA transcription, but mRNA detection alone does not guarantee functional protein expression. The investigators therefore also performed immunohistochemistry using anti-OXTR antibodies, confirming receptor protein at the cellular level. Radioligand binding assays with tritiated oxytocin ([³H]-OT) demonstrated specific, saturable binding in penile tissue membrane preparations, with affinity characteristics (Kd ≈ 1.5 nM) consistent with the known pharmacology of the OXTR in uterine tissue (Kimura et al., 1992).

Developmental Expression Patterns

The most intriguing aspect of OXTR in the penis concerns its developmental regulation. The human penis undergoes a complex morphogenetic programme beginning in the first trimester of gestation, with formation of the genital tubercle, urethral groove fusion, and differentiation of the cavernous bodies occurring between weeks 8 and 16 of development (Baskin et al., 2001). After birth, further penile growth occurs during the neonatal period (driven by a transient postnatal testosterone surge – the “mini-puberty” of infancy) and again at puberty.

Prenatal OXTR Expression

Ivell et al. (1997) examined OXTR expression in fetal human tissues and reported that receptor mRNA is detectable in the developing genital tract from approximately 12 weeks of gestation. In penile tissue specifically, OXTR expression appears to be temporally correlated with the period of active smooth muscle differentiation in the developing corpus cavernosum (weeks 12–20). This temporal correlation suggests – though does not prove – a functional role for oxytocin signalling in directing smooth muscle cell proliferation or differentiation during penile organogenesis.

The developmental timing is noteworthy because it coincides with the window of androgen action critical for masculinisation of the external genitalia. Testosterone (converted locally to dihydrotestosterone by 5α-reductase) drives penile growth and cavernous body formation during this period. Whether OXTR expression in developing penile tissue is androgen-regulated remains an open question, though evidence from other tissues suggests complex interactions between steroid hormones and oxytocin receptor expression. In the myometrium, oestrogen dramatically upregulates OXTR expression (Fuchs et al., 1982), while progesterone suppresses it – but analogous hormonal regulation of penile OXTR has not been systematically investigated.

Postnatal and Pubertal Changes

Limited data exist on postnatal changes in penile OXTR expression. Einspanier & Ivell (1997) analysed tissue from adult surgical specimens and found robust OXTR expression in the mature penis, but a systematic developmental time course – comparing neonatal, prepubertal, pubertal, and adult tissue – has not been published for the human. In the rat, Argiolas & Melis (2004) demonstrated that penile OXTR expression increases with sexual maturation, reaching adult levels around postnatal day 60 (coinciding with full sexual maturity in the rat).

The pubertal increase in penile OXTR likely reflects the growth and differentiation of cavernosal smooth muscle during pubertal penile enlargement. Whether oxytocin receptor signalling actively contributes to pubertal penile growth – or is simply a passenger effect reflecting the expansion of smooth muscle mass – remains to be determined.

Cell Types Expressing OXTR in the Penis

Immunohistochemical studies have identified several cell populations expressing OXTR in human penile tissue:

Cavernosal smooth muscle cells. The trabecular smooth muscle of the corpus cavernosum shows consistent OXTR immunoreactivity. These cells are the primary effectors of erection, and their contraction or relaxation determines the haemodynamic state of the erectile bodies. OXTR expression in these cells provides a mechanism for direct oxytocin modulation of erectile function.

Vascular smooth muscle. Smooth muscle cells of the penile arteries (helicine arteries and dorsal penile artery) express OXTR. Oxytocin-mediated contraction of these cells could modulate penile blood flow, contributing to the regulation of tumescence and detumescence.

Endothelial cells. Some OXTR expression has been reported in the endothelium of penile blood vessels. This is consistent with the known pro-angiogenic and vasoactive effects of oxytocin in other vascular beds, and with the observation that oxytocin stimulates endothelial nitric oxide synthase (eNOS) activity (Thibonnier et al., 1999).

Fibroblasts of the tunica albuginea. Low-level OXTR expression has been detected in the fibrous capsule surrounding the cavernous bodies. The functional significance of this expression is unclear, though it could relate to tissue remodelling during development or pathological fibrosis (as seen in Peyronie’s disease).

Functional Implications of Developmental OXTR Expression

Smooth Muscle Differentiation

One hypothesis for the developmental role of penile OXTR is that oxytocin signalling contributes to the differentiation of smooth muscle precursor cells into mature contractile smooth muscle during cavernous body formation. Oxytocin has been shown to promote smooth muscle differentiation in other tissues – notably the myometrium and mammary myoepithelium – through calcium-dependent activation of transcription factors including nuclear factor of activated T-cells (NFAT) and serum response factor (SRF) (Devost & Bhatt, 2004).

If oxytocin serves a similar differentiative function in penile smooth muscle, disruption of OXTR signalling during the critical developmental window could theoretically impair cavernosal smooth muscle formation. This remains speculative, as no studies have examined penile phenotypes in OXTR-knockout mice in detail.

Paracrine Oxytocin Signalling

The question of ligand availability is central to interpreting developmental OXTR expression. During fetal life, circulating oxytocin is primarily of maternal origin, crossing the placenta in limited quantities. However, local oxytocin synthesis has been demonstrated in fetal tissues, including the fetal testis, where Leydig cells produce oxytocin that acts in a paracrine fashion to regulate seminiferous tubule contractility (Ivell et al., 1997). Whether similar local oxytocin production occurs in the developing penis has not been directly investigated, though the expression of both the oxytocin peptide and its receptor in the fetal male reproductive tract suggests an autocrine/paracrine signalling system.

Comparative Developmental Biology

OXTR expression during genital development is not unique to humans. In the rat, OXTR mRNA has been detected in the developing genital tract from embryonic day 18 (Breton et al., 2001). In sheep – a species in which penile development has been extensively studied due to the effects of endocrine-disrupting chemicals – OXTR expression in the fetal penis has been reported during the window of masculinisation (Sweeney et al., 2000).

Cross-species conservation of developmental penile OXTR expression strengthens the argument for a functional role, as evolutionary conservation of expression patterns generally implies biological importance. The precise developmental function may differ between species, however, given differences in penile anatomy (e.g., the fibrovascular penis of ruminants versus the vascular penis of primates and rodents).

OXTR and Reproductive Tract Development: Broader Context

The developing penis is part of a broader reproductive system in which oxytocin receptors are expressed at multiple sites. In the fetal and developing male, OXTR has been demonstrated in:

Testis: Sertoli cells and Leydig cells express OXTR, where oxytocin regulates seminiferous tubule contractility and steroidogenesis (Nicholson & Jenkin, 1995). Epididymis: OXTR mediates smooth muscle contraction facilitating sperm transport (Einspanier & Ivell, 1997). Prostate: Prostatic smooth muscle and epithelium express OXTR, with oxytocin modulating prostatic secretion and growth (Nicholson & Jenkin, 1995). Vas deferens: OXTR-mediated contraction of the vas deferens contributes to the emission phase of ejaculation (Frayne & Bhatt, 2003).

Viewed in this broader context, penile OXTR expression is part of a coordinated programme of oxytocin receptor deployment across the entire male reproductive tract, potentially coordinating the development and later function of multiple tissues involved in reproduction.

Clinical and Translational Perspectives

Congenital Penile Anomalies

The developmental expression of OXTR in the penis raises the question of whether dysregulated oxytocin signalling could contribute to congenital penile anomalies. Hypospadias – a common birth defect involving incomplete fusion of the urethral folds – occurs during the same developmental window in which penile OXTR expression has been detected (weeks 8–16). While hypospadias is primarily associated with androgen insufficiency or disrupted androgen signalling (Baskin et al., 2001), the potential contribution of aberrant oxytocin receptor signalling has not been investigated.

Similarly, micropenis – defined as a stretched penile length more than 2.5 standard deviations below the mean – results from inadequate androgen stimulation during fetal or neonatal life. If oxytocin receptor signalling contributes to smooth muscle growth during these periods, its disruption could theoretically compound the effects of androgen deficiency, though this remains entirely hypothetical.

Endocrine Disruption

The demonstration that OXTR expression is sensitive to hormonal milieu raises concerns about the effects of endocrine-disrupting chemicals (EDCs) on penile development. Several EDCs – including bisphenol A, phthalates, and organochlorine pesticides – have been shown to alter oxytocin receptor expression in reproductive tissues (Bosch & Neumann, 2012). Whether developmental exposure to these chemicals affects penile OXTR expression and, consequently, penile smooth muscle differentiation is an important unanswered question with potential public health implications.

Gaps in Knowledge and Future Directions

Despite the importance of the Einspanier and Ivell findings, several significant gaps remain in our understanding of OXTR in the developing penis:

First, a detailed developmental time course of penile OXTR expression – from early fetal life through puberty – has not been established in humans. Ethical and practical constraints limit access to fetal and paediatric penile tissue, making this a challenging area to study directly. Second, the functional consequences of OXTR activation in developing penile tissue (as distinct from adult tissue) have not been characterised. It is possible that OXTR signalling in fetal or neonatal penile tissue engages different downstream pathways than in the adult, given the well-documented changes in G-protein coupling and receptor desensitisation that occur during development. Third, the OXTR-knockout mouse model has not been systematically examined for penile phenotypes. Detailed histological and functional analysis of penile tissue in OXTR⁻/⁻ mice could provide definitive evidence for or against a developmental role.

For additional reference material and citations, see the references page.

Frequently Asked Questions